Gross Profit Trends Compared: Pharming Group N.V. vs Bausch Health Companies Inc.

Pharming vs. Bausch: A Decade of Profit Trends

__timestampBausch Health Companies Inc.Pharming Group N.V.
Wednesday, January 1, 2014600890000021595165
Thursday, January 1, 201578538000006590427
Friday, January 1, 2016706300000011768542
Sunday, January 1, 2017617600000092587038
Monday, January 1, 20186029000000129203843
Tuesday, January 1, 20196251000000165412447
Wednesday, January 1, 20205778000000203056430
Friday, January 1, 20216040000000169670071
Saturday, January 1, 20225760000000188060000
Sunday, January 1, 20236198000000220104000
Loading chart...

Igniting the spark of knowledge

Gross Profit Trends: A Tale of Two Companies

In the ever-evolving pharmaceutical landscape, understanding financial trends is crucial. This analysis compares the gross profit trajectories of Pharming Group N.V. and Bausch Health Companies Inc. from 2014 to 2023. Bausch Health, a major player, consistently reported robust profits, peaking in 2015 with a 30% increase from the previous year. However, a slight decline followed, with a 7% drop by 2022. In contrast, Pharming Group N.V. showcased a remarkable growth story. Starting with modest profits in 2014, they achieved a staggering 920% increase by 2023. This growth underscores Pharming's strategic advancements and market adaptability. While Bausch Health remains a giant, Pharming's upward trajectory highlights the dynamic nature of the industry. Investors and stakeholders should note these trends as they reflect broader market shifts and company-specific strategies.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025